A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate–prednisone

Document Details

Document Type
Pub Defense Publication
Publication Date
Feb 01, 2018
Source ID
10.1093/annonc/mdx689

Entities

People

  • A.h. Bryce
  • B.a. Costello
  • B.p. Mcmenomy
  • B.w. Eckloff
  • D.w. Hillman
  • E.d. Wieben
  • F. Ou
  • F. Quevedo
  • F. Xie
  • H. Sicotte
  • H.c. Pitot
  • Hao Huang
  • J. Jen
  • K.r. Kalari
  • Liqiang Wang
  • M. Ellingson
  • M. Gormley
  • Manish Kohli
  • P. Barman
  • P. Eiken
  • P. Yin
  • P.t. Vedell
  • R. Jimenez
  • R.e. Carlson
  • R.m. Weinshilboum
  • Rongjun Qin
  • S. Qin
  • S.m. Dehm
  • S.n. Hart
  • T.d. Atwell
  • Tak‐San Ho
  • V. Bhargava
  • W. Tan
  • Yang Li
  • Z. Ye

Organizations

  • National Institutes of Health
  • Prostate Cancer Foundation
  • United States Department of Defense